Studies about the effectiveness of paxlovid after marketing have given conflicting results so far. Certainly, covid-19 rebound infection is a problem with the currently recommended regimen and paxlovid should not be used in young, low risk population.
Answered 10/28/2022
0 views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question